LabStyle to take on iBGStar with smartphone-enabled glucose meter

By Aditi Pai
11:10 am

plasma_04Israel-based LabStyle Innovations, which is developing a smartphone-based glucose meter, has raised $10 million by common stock that the company plans to accredited investors. The company plans to use the money to develop, market and manufacture Dario, its smartphone-enabled diabetes management system. Dario does not have a CE mark nor does it have FDA approval. LabStyle CEO Dr. Oren Fuerst aims to launch the product in Europe soon, according to a company press release.

Dario is a small glucose meter which syncs with a companion app and works with Apple iPhone 5, iPads and iPods and Android devices like the Samsung Galaxy S4 and Tab. The app includes a nutrition guide, logbook, insulin calculator and monitoring system. A data overview within the app displays a radial chart of blood glucose measurements. It also shows how many measurements were above, below or within the blood glucose target range and if they were before or after a meal.

While LabStyle has remained fairly quiet, over the past year, the device caught the attention of several diabetes blogs including DiabetesMine and ASweetLife.

The company also plans to prepare a FDA 510(k) application sometime this year.

The iBGStar, which was AgaMatrix and Sanofi co-developed, was the first smartphone-enabled blood glucose meter to integrate directly with a smartphone and receive FDA clearance in 2011. Unlike Dario, which will work with both iOS and Android, iBGStar only connects to Apple devices.


The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!